StockData
Veru Inc. logo

Veru Inc. (VERU) stock

VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 6/30
$2.31+0.17 (+7.94%)

Close on Nov 18, 2026Market cap $39.39MP/E –Yield –

Veru pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Veru's pe ratio was 56.2× on Jan 31, 2022, against 7.5× a year earlier. Over the last 5 years it ranged from 7.0× to 112.0×, with a median of 16.2×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jan 31, 202256.2×−7.5
2021Dec 31, 202163.7×−38.3
2017Jan 31, 2017102.0×+11.0
2016Dec 30, 201691.0×+81.3
2015Dec 31, 20159.7×−39.3
2014Dec 31, 201449.0×+32.0
2013Dec 31, 201317.0×+3.5
2012Dec 31, 201213.5×−10.2
2011Dec 30, 201123.7×+0.0
2010Dec 31, 201023.7×+4.0
2009Dec 31, 200919.7×–

More Veru figures

See a number that looks wrong?